Members of the neurexin gene family, neurexin 1 (NRXN1), neurexin 2 (NRXN2), and neurexin 3 (NRXN3) encode important components of synaptic function implicated in autism and other neurodevelopmental/neuropsychiatric disorders. Loss of function variants have been reported predominantly in NRXN1, with fewer such variants detected in NRXN2 and NRXN3. Evidence for segregating NRNX3 variants has particularly been lacking. Here, we report identification by chromosomal microarray analysis of a rare exonic deletion affecting the NRXN3 alpha isoform in a three-generation Chinese family. The proband, a 7-year-old boy, presented with motor and language delay and met the clinical diagnostic criteria for autism. He also presented with moderate intellectual disability, attention-deficit hyperactivity disorder and facial dysmorphic features.
Members of the neurexin gene family, neurexin 1 (NRXN1), neurexin 2 (NRXN2), and neurexin 3 (NRXN3) encode important components of synaptic function implicated in autism and other neurodevelopmental/neuropsychiatric disorders. Loss of function variants have been reported predominantly in NRXN1, with fewer such variants detected in NRXN2 and NRXN3. Evidence for segregating NRNX3 variants has particularly been lacking. Here, we report identification by chromosomal microarray analysis of a rare exonic deletion affecting the NRXN3 alpha isoform in a three-generation Chinese family. The proband, a 7-year-old boy, presented with motor and language delay and met the clinical diagnostic criteria for autism. He also presented with moderate intellectual disability, attention-deficit hyperactivity disorder and facial dysmorphic features.
The mother and maternal grandfather, both deletion carriers, presented with variable degrees of language and communication difficulties, as well as neuropsychiatric problems such as schizophrenia and temper tantrums. A compilation of sporadic cases with deletions involving part or all of NRXN3 revealed that 9 of 23 individuals (39%) displayed features of autism. The evidence for cosegregation in our family further supports a role for NRXN3 in autism and neurodevelopmental/neuropsychiatric disorders but demonstrates intrafamily variable expressivity due to this NRXN3 deletion, with schizophrenia and facial dysmorphism being potential novel features of NRXN3 haploinsufficiency.
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| INTRODUCTION
Neurexins are presynaptic cell-adhesion molecules encoded by paralogous genes, NRXN1, NRXN2, and NRXN3. Each of these encodes alpha and beta isoforms (Sudhof, 2008) . Neurexins are cell-surface receptors that bind neuroligins to form a Ca 2+ -dependent neurexin/neuroligin complex at synapses in the central nervous system; they are required for efficient neurotransmission and play key roles in synaptic contacts and function (Reissner, Klose, Fairless, & Missler, 2008; Tabuchi & Sudhof, 2002 ). All three genes had been implicated in autism spectrum disorders (ASDs) (Autism Genome Project Consortium et al., 2007; Born et al., 2015; Boyle et al., 2015; Ching et al., 2010; Dachtler et al., 2014; Feng et al., 2006; Gauthier et al., 2011; Gjørlund et al., 2012; Glessner et al., 2009; Kim et al., 2008; Liu et al., 2012; Mohrmann, GillessenKaesbach, Siebert, Caliebe, & Hellenbroich, 2011; Rujescu et al., 2009; Stessman et al., 2017; Vaags et al., 2012) .
Loss of function variants had been mostly identified in NRXN1
among patients with neurodevelopmental or neuropsychiatric disorders, supporting NRXN1 as a susceptibility gene for ASD, schizophrenia, and intellectual disability (Feng et al., 2006; Autism Genome Project Consortium et al., 2007; Kim et al., 2008; Glessner et al., 2009; Rujescu et al., 2009; Ching et al., 2010; Gauthier et al., 2011; Liu et al., 2012; Gjørlund et al., 2012; Stessman et al., 2017) . Variable expressivity and incomplete penetrance frequently were observed (Lowther et al., 2017; Woodbury-Smith et al., 2017) . Variants involving NRXN2 and NRXN3 are much rarer but reports are accumulating (Born et al., 2015; Boyle et al., 2015; Dachtler et al., 2014; Gauthier et al., 2011; Mohrmann et al., 2011; Vaags et al., 2012) . Several findings support a role for NRXN2 in autism, but the contribution of NRXN2 to brain function might be less than other NRXN genes as NRXN2 deletion does not seem to impair cognitive competence (Born et al., 2015; Boyle et al., 2015; Dachtler et al., 2014; Gauthier et al., 2011; Mohrmann et al., 2011 Cingöz et al., 2011; Vaags et al., 2012; Griswold et al., 2012; Riegel, Moreira, Espirito Santo, Toralles, & Schinzel, 2014; Faheem et al., 2015; Nicita et al., 2015;  https://decipher.sanger.ac.uk/).
Familial exonic NRXN3 deletions were reported previously in autistic children from four unrelated pedigrees of Western origin. Among the four pedigrees, one deletion was inherited from a carrier mother without ASD diagnosis, another from an unaffected father. The third deletion was inherited from an affected father with subclinical autism and the fourth deletion was de novo. Thus, the four pedigrees provided limited evidence for cosegregation of the deletion with a neurodevelopmental phenotype (Vaags et al., 2012) . NRXN3 has also been implicated in neuropsychiatric disorders such as schizophrenia (Hu et al., 2013) , but overall, studies of NRXN3 in autism and other neuropsychiatric disorders are quite limited. Here, we describe a three-generation Chinese family carrying a deletion at 14q24.3-q31.1 involving the NRXN3 alpha isoform (Figure 1) . This pedigree provides important supporting evidence for the association between NRXN3 and neurodevelopmental/ neuropsychiatric conditions, including autism.
| CASE PRESENTATION
The proband (F-001) was one of two children of nonconsanguineous parents, the product of an uneventful pregnancy. His younger brother (F-002) was healthy. The proband was delivered at 38 weeks of gestation with normal birth measurements: weight 3.2 kg (40th centile), length 51 cm (65th centile), and head circumference 34.2 cm (40th centile). Apgar scores were all 9. No feeding problem was noted after birth. His growth development was within normal range: he weighed 24 kg (60th centile), his height was 121.8 cm (45th centile), and his head circumference was 51.4 cm (45th centile) at the age of 7 years, but his motor development was delayed: he raised his head at 4 months, sat alone at 1 year and could walk independently at 2 years. His language development was significantly delayed; he only 
| FMR1 gene testing
FMR1 testing was carried out for the proband following the manufacturer's instructions as described elsewhere (Biancalana & Macpherson, 2004 ). or 1000G (http://www.1000genomes.org), and our internal database.
| Chromosomal microarray analysis
The pathogenicity of the sequence variants was interpreted according to the ACMG and Genomics/Association for Molecular Pathology guidelines (Richards et al., 2015) .
All data were collected with the informed consent of the patients.
Ethical approval for the present study was obtained from Dongguan
Maternal and Child Health Care Hospital.
| RESULTS
The proband had a normal karyotype and a normal FMR1 repeat number but CMA detected a 222 Kb heterozygous microdeletion at 14q24.3-q31.1 with genomic coordinates 79, 258, 480, 738 (GRCh37/hg19), encompassing exons 6-12 of the alpha isoform of NRXN3 (Figure 3 ). The NRXN3 deletion was also detected in the mother and the maternal grandfather. The other members of the large
Chinese family showed normal copy number in this region. We also performed WES tests for F-001, −004, and −008 to search for variants that might contribute to the phenotype. No clinical significant sequence variants were identified.
| DISCUSSION
CNVs involving NRXN1 have been associated with intellectual disability, language delay, autism, and several psychiatric disorders, in particular, schizophrenia (Ching et al., 2010; Feng et al., 2006; Gauthier et al., 2011; Gjørlund et al., 2012; Glessner et al., 2009; Kim et al., 2008; Liu et al., 2012; Rujescu et al., 2009; Stessman et al., 2017) , indicating a broad phenotypic spectrum for NRXN mutations. In the four previously reported pedigrees with NRXN3 deletion, the deletion carrying probands were all diagnosed with autism. In addition, three of the probands also presented with aggression, anger, and anxiety.
One deletion-carrying father presented with subclinical autism and one deletion-carrying mother presented with social difficulties, language delay, and anxiety but no autism (Vaags et al., 2012 Deletions involving NRXN3 have rarely but sporadically been reported in databases and publications, so we compiled and compared these cases in Table 1 and Figure 4 . We compared the phenotypes of all 23 cases carrying NRXN3 deletions and found that nine patients (39%)
had ASD, as the most consistent feature of individuals with NRXN3 deletion. Other features included language delay, social difficulties, intellectual disability, ADHD, temper tantrums, anxious, and aggressive and obsessive behaviors (Schlade-Bartusiak et al., 2008; Cingöz et al., 2011; Vaags et al., 2012; Griswold et al., 2012; Riegel et al., 2014; Faheem et al., 2015; Nicita et al., 2015;  https://decipher.sanger.ac.uk/). Our
The panel shows a genome view of all deletion cases (red colored custom tracks) relative to the genomic coordinates at 14q24.3q31.1 region, extracted from Human Genome Build 37 (hg19). The minimal overlapping region of deletion in the four patients who carry large deletions involves only NRXN3, which is surrounded by black boxes [Color figure can be viewed at wileyonlinelibrary.com] proband's maternal grandfather was diagnosed with schizophrenia, which was a rare phenotype in NRXN3 deletion patients. It was interesting to note that our proband had distinctive facial features which had not been described in those patients who carried exonic deletions within NRXN3. However, we found that four patients who carried large deletions at 14q24.3-q32 that overlap NRXN3 and other genes also presented with facial dysmorphism. We observed that our proband and these four patients shared similar facial features, such as hypertelorism, flat nose bridge, long broad philtrum, auricle dysplasia, and mild micrognathia (Cingöz et al., 2011; Nicita et al., 2015; Riegel et al., 2014; Schlade-Bartusiak et al., 2008) . Whether or not the NRXN3 deletion is responsible for facial dysmorphism requires further investigation.
In conclusion, we identified a rare exonic deletion of NRXN3 in a three-generation Chinese family. The cosegregation evidence further supported a role for NRXN3 in autism and other neurodevelopmental/ neuropsychiatric disorders. By comparing the clinical phenotypes of all 23 patients with NRXN3 deletions, we confirmed that patients carrying exonic NRXN3 deletions display variable clinical features and reduced penetrance for autism. Facial dysmorphism and schizophrenia might be novel phenotypes which need to be further studied.
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